Consultant in Haemato-Oncologist | Barts Health NHS Trust

Dyddiad hysbysebu:	04 Chwefror 2026
Cyflog:	Heb ei nodi
Gwybodaeth ychwanegol am y cyflog:	£109,725 - £145,478 per annum
Oriau:	Llawn Amser
Dyddiad cau:	06 Mawrth 2026
Lleoliad:	London, EC1A 7BE
Cwmni:	Barts Health NHS Trust
Math o swydd:	Parhaol
Cyfeirnod swydd:	7785541/259-MED7785541SBH

Crynodeb

Consultant Haemato-Oncologist with an interest in Myeloma and associated Plasma Cell Disorders

10PAs

This post is for a Substantive Consultant to join the Department of Haemato-Oncology at the Barts Cancer Centre, based at St Bartholomew’s Hospital in the City of London.
Barts Health NHS Trust is a provider of an extended network for the care of patients with haematological malignancies and is one of the six Level 3 facilities within London.
The Barts Myeloma team was recently assessed as Excellent when awarded Clinical Service Excellence Program status by Myeloma UK and has a large and varied clinical trials portfolio.
The successful candidate will join the existing multi-disciplinary team in the provision of specialist inpatient and outpatient services to patients with MGUS, Smouldering Myeloma, Multiple Myeloma, Amyloidosis, MGRS and other MGCS.
The post holder will be expected to work three outpatient clinics a week; two general Myeloma clinics weekly, and about one-in-three weeks Autografting clinic, supervising the nurse led MGUS and Revlimid Maintenance clinic on other weeks.
They will be expected to deliver weekday specialist Myeloma ward attending for about 14 weeks a year including leading two ward rounds a week and coordination of a multi-disciplinary team of specialist nurses, doctors in training and allied health professionals

• To be an active member of the Cancer Centre and help deliver the departmental mission of excellence in clinical care and teaching.

• To contribute to the provision of a comprehensive, efficient and high quality evidence- based Haemato-oncology service, with continuing responsibility for the care of patients in their charge, including all administrative duties associated with patient care.

• Leadership, development and organisation of the services in the charge of the post holder in line with the Trust/Divisional business plans. Full participation in the management of the Barts Cancer Centre (BCC). Liaison and communication with the Divisional Director, Clinical Director, Lead Clinicians and the General and Service Managers.

• To provide clinical care for patients within Haemato-oncology, including inpatients and outpatients, providing specialist advice and a referral service for other clinicians in the Trust.

• To be responsible for Clinical Audit activities, which is an essential and regular part of clinical practice.

• To participate in the Trust’s clinical governance activities, and to encourage and foster
improvements in the quality and standards of clinical services.

• To provide clinical leadership in Haemato-oncology within Barts Health NHS Trust.

• To participate in undergraduate teaching of Haemato-oncology.

• To have corporate and individual responsibility for the professional management of doctors in training.



Barts Health is one of the largest NHS trusts in the country, and one of Britain’s leading healthcare providers.

The Barts Health group of NHS hospitals is entering an exciting new era on our improvement journey to becoming an outstanding organisation with a world-class clinical reputation. Having lifted ourselves out of special measures, we now have the impetus and breathing space to chart a fresh course in which we are continually striving to improve all our services for patients.

Our vision is to be a high-performing group of NHS hospitals, renowned for excellence and innovation, and providing safe and compassionate care to our patients in east London and beyond. That means being a provider of excellent patient safety, known for delivering consistently high standards of harm-free care and always caring for patients in the right place at the right time. It also means being an outstanding place to work, in which our WeCare values and behaviours are visible to all and guide us in how we work together.

We strive to live by our WeCare values and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.

• To contribute to the provision of comprehensive, efficient and high-quality care throughout the treatment and management pathway of patients with haematological malignancies.

• To help co-ordinate the provision of a consolidated service across all sites in the Trust. To note that there is no diagnostic or laboratory haematology component to this post – Specialist Integrated Haemtological Malignancy Diagnostic Services (SIHMDS) is undertaken by the regional SIHMDS service based at the Royal London Hospital. Consultative general haematology services are also provided by Clinical Haematology.

• To undertake administrative duties associated with the care of patients in their charge and the running of their clinics or departments.

• To participate in the consultant on-call rota and provide cover for colleagues in time of absence and leave when required. There are separate on-call rotas for non-malignant haematology, paediatric haematology, red cell haematology and Haemostasis/Thrombosis.

• To have a key role in providing a high-quality clinical service for patients with haematological malignancies, to increase access of patient enrolment within clinical trials, and to integrate the patient pathway within Barts Health NHS Trust and its referring hospitals.

• To maintain up-to-date specialist knowledge and provide evidence based care for all patients.

• To attend multidisciplinary team meetings.

• To liaise effectively and on a timely basis with General Practitioners, Community Services and all health care agencies.

• To initiate and promote research and development activities with a clear focus on relevant clinical and scientific priorities.




This advert closes on Sunday 1 Mar 2026